Browsing: Therapeutic Areas

Insilico Medicine and SK Biopharmaceuticals have announced a collaboration at the BIO 2026 International Convention to develop AI-driven drug candidates…

Novartis plans to pursue more bolt-on acquisitions to enhance its portfolio, with a continued focus on strategic therapeutic areas including…

Over the past decade, major pharmaceutical companies have shifted towards a “pure-play” model by divesting their consumer health divisions, which…

Medincell, a biopharmaceutical company focused on long-acting injectable treatments, has appointed Edna Venneker, MD, as Chief Medical Officer. Venneker brings…

In 2025, the biotech sector faced significant uncertainty characterized by ongoing funding challenges and the complexities of drug development. A…

A recent report by the IQVIA Institute highlights significant trends in clinical trial activity for 2025, reflecting both resilience and…

Harbour BioMed announced its interim results for the first half of 2026, showcasing significant advancements in its biopharmaceutical efforts, particularly…

The pharmaceutical industry is increasingly focused on formulation innovation as a means of differentiation beyond just active ingredients, particularly in…

Eli Lilly (LLY) and AbbVie (ABBV) are two prominent U.S. pharmaceutical companies with diverse and robust portfolios. Lilly has made…

Pfizer (PFE) and Bristol Myers Squibb (BMY) continue to lead in the competitive oncology market amid rising cancer cases globally.…